Stefan Gradl;Li Ren;Steven Mark Wenglowsky;Ellen Laird;David Moreno
发明人:
Stefan Gradl,Ellen Laird,David Moreno,Li Ren,Steven Mark Wenglowsky
申请号：
US13393076
公开号：
US20120157452A1
申请日:
2010.08.27
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. [FORMULA I]
